amphotericin b

amphotericin b is a lipid of Polyketides (PK) class. Amphotericin b often locates in Mitochondria.

Cross Reference

Introduction

To understand associated biological information of amphotericin b, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with amphotericin b

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with amphotericin b?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What lipids are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What genes are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with amphotericin b

Download all related citations
Per page 10 20 50 100 | Total 10373
Authors Title Published Journal PubMed Link
Song Z et al. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. 2019 Carbohydr Polym pmid:30446143
Rochelle do Vale Morais A et al. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion. 2018 Exp. Parasitol. pmid:30075233
White A et al. Case 4: Weakness and Headaches in a 14-year-old Boy. 2018 Pediatr Rev pmid:30068745
Tomotaki S et al. Mucor mycelial thrombosis of the portal vein in an extremely low-birthweight infant. 2018 Pediatr Int pmid:30058248
Abongomera C et al. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study. 2018 PLoS Negl Trop Dis pmid:29799869
Ramos JM et al. Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain. 2018 Paediatr Int Child Health pmid:29790825
Wang X et al. The first isolate of Candida auris in China: clinical and biological aspects. 2018 Emerg Microbes Infect pmid:29777096
Anwar A et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. 2018 Parasitol. Res. pmid:29218442
Brilhante RSN et al. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil. 2018 Int. J. Antimicrob. Agents pmid:29592837
Pinhata JMW et al. Evaluation of inhibitors for development of a selective medium for isolation of Leptospira spp. from clinical samples. 2018 Lett. Appl. Microbiol. pmid:29575146
Alfano G et al. Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature. 2018 Transplant. Proc. pmid:29573830
Vande Velde G et al. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms. 2018 Int. J. Antimicrob. Agents pmid:29572043
Richter AR et al. Pickering emulsion stabilized by cashew gum- poly-l-lactide copolymer nanoparticles: Synthesis, characterization and amphotericin B encapsulation. 2018 Colloids Surf B Biointerfaces pmid:29413597
Hamzavi SS et al. Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl. 2018 Pediatr. Infect. Dis. J. pmid:29424815
Oliveira VM et al. Black and white teas as potential agents to combine with amphotericin B and protect red blood cells from amphotericin B-mediated toxicity. 2018 Braz J Biol pmid:29412247
Evrard S et al. Disseminated histoplasmosis: case report and review of the literature. 2018 Acta Clin Belg pmid:28954600
Kumar M et al. Central Line-Associated Mucor velutinosus Bloodstream Infection in an Immunocompetent Pediatric Patient. 2018 J Pediatric Infect Dis Soc pmid:29373689
Hoenigl M et al. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study. 2018 Mycoses pmid:29112326
Masuzawa T et al. Characterization of Leptospira species isolated from soil collected in Japan. 2018 Microbiol. Immunol. pmid:29105847
Lewis PO et al. Successful stepdown treatment of pulmonary histoplasmosis with thrice-weekly liposomal amphotericin B in a hospital-associated, outpatient infusion centre: A case report. 2018 J Clin Pharm Ther pmid:28806478